GlassScriptPhysician profile
Mara Dawne Carson
NPI 1861038044
$2,619.58
in general payments reported to CMS, 2019-2025
30 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $378 · 2022: $788 · 2023: $477 · 2024: $549 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $906.41 | 2021-2025 | |
| Pfizer INC. | $299.28 | 2023-2025 | |
| Novo Nordisk INC | $262.55 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Sunovion Pharmaceuticals INC. | $174.01 | 2021-2022 | |
| Boston Scientific Corporation | $171.07 | 2025 | Jetstream Sc, Ranger, General - Pain Management |
| Eisai INC. | $101.44 | 2024-2025 | |
| Indivior INC. | $97.85 | 2023-2024 | Sublocade |
| Lilly USA, LLC | $76.36 | 2021-2024 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Pharmaceuticals LP | $43.71 | 2024 | Airsupra, Breztri |
| Sanofi-Aventis U.S. LLC | $42.15 | 2022 | |
| Amgen INC. | $40.80 | 2021 | |
| Medtronic, INC. | $37.01 | 2023 | Interstim, Minimed 780g |
| Cranial Technologies, INC | $32.41 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.81 | 2023-2024 | Xifaxan |
| Inspire Medical Systems, INC. | $30.51 | 2025 | Inspire |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $28.82 | 2025 | Venacure 1470 Pro |
| Mannkind Corporation | $26.59 | 2024 | |
| Novartis Pharmaceuticals Corporation | $20.42 | 2025 | |
| Nestle Healthcare Nutrition INC. | $19.96 | 2022 | |
| Sanofi Pasteur INC. | $19.57 | 2023 | |
| Merck Sharp & Dohme LLC | $19.15 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
| Vanda Pharmaceuticals INC. | $19.06 | 2023 | Hetlioz |
| Orexo US, INC. | $18.64 | 2023 | Zubsolv |
| Acella Pharmaceuticals, LLC | $17.81 | 2025 | NP Thyroid 60 |
| Xeris Pharmaceuticals, INC. | $15.59 | 2023 | Gvoke Hypopen |
| Grifols USA, LLC | $14.59 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.91 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.04 | 2025 | Lifevest |
| Lucid Diagnostics INC. | $12.88 | 2022 | |
| Mylan Specialty L.P. | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mara Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.